Related Experiment Video

Updated: Aug 23, 2026

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

SUPPLEMENT REPORT OF THE TASK FORCE ON BIOMATERIALS TO THE CARDIOLOGY ADVISORY COMMITTEE OF THE NHLBI

Pierre M. Galletti1, John L. Brash, Kenneth H. Keller

  • 1National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health, Bethesda, Maryland 20014. (Reprinted by permission.).

Cardiovascular Diseases
|September 1, 1978
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering11:32

Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering

Published on: December 20, 2010

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model11:49

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Published on: September 9, 2011

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...